LU74732A1 - - Google Patents

Info

Publication number
LU74732A1
LU74732A1 LU74732A LU74732A LU74732A1 LU 74732 A1 LU74732 A1 LU 74732A1 LU 74732 A LU74732 A LU 74732A LU 74732 A LU74732 A LU 74732A LU 74732 A1 LU74732 A1 LU 74732A1
Authority
LU
Luxembourg
Application number
LU74732A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74732A1 publication Critical patent/LU74732A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
LU74732A 1975-04-09 1976-04-09 LU74732A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504049A SE7504049L (en) 1975-04-09 1975-04-09 COLON PREPARATION

Publications (1)

Publication Number Publication Date
LU74732A1 true LU74732A1 (en) 1977-02-04

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74732A LU74732A1 (en) 1975-04-09 1976-04-09

Country Status (12)

Country Link
BE (1) BE840552A (en)
DE (1) DE2614296A1 (en)
DK (1) DK153376A (en)
FI (1) FI56772C (en)
FR (1) FR2306710A1 (en)
GB (1) GB1538123A (en)
IE (1) IE42793B1 (en)
LU (1) LU74732A1 (en)
NL (1) NL7603600A (en)
NO (1) NO761101L (en)
NZ (1) NZ180552A (en)
SE (1) SE7504049L (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2471186A1 (en) * 1979-12-10 1981-06-19 Roussel Uclaf NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
DE3776116D1 (en) * 1986-12-30 1992-02-27 American Cyanamid Co COMPOSITION CONTAINING A POLYCARBOPHIL.
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Colonic drug delivery system
ATE185267T1 (en) * 1990-05-04 1999-10-15 Perio Prod Ltd SYSTEM FOR DRUG DELIVERY IN THE COLON
DE9212938U1 (en) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim Calcium polycarbophil preparation for taking high doses of active ingredients
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
WO2018191752A1 (en) 2017-04-14 2018-10-18 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders

Also Published As

Publication number Publication date
GB1538123A (en) 1979-01-10
SE7504049L (en) 1976-10-10
FI56772C (en) 1980-04-10
IE42793B1 (en) 1980-10-22
NL7603600A (en) 1976-10-12
NO761101L (en) 1976-10-12
BE840552A (en) 1976-10-11
FR2306710A1 (en) 1976-11-05
IE42793L (en) 1976-10-09
DE2614296A1 (en) 1976-10-21
FR2306710B1 (en) 1979-07-13
FI760948A (en) 1976-10-10
DK153376A (en) 1976-10-10
NZ180552A (en) 1978-07-28
FI56772B (en) 1979-12-31

Similar Documents

Publication Publication Date Title
FR2306710B1 (en)
JPS5218678U (en)
FR2314205B3 (en)
JPS5247507U (en)
JPS5515915Y2 (en)
FR2314701B3 (en)
JPS5629877Y2 (en)
JPS555496B2 (en)
JPS5288007U (en)
JPS51152673U (en)
JPS51109989U (en)
JPS51107650A (en)
CS176872B1 (en)
JPS5263391U (en)
CH607471A5 (en)
CH536275A4 (en)
CH583647A5 (en)
CH604482A5 (en)
BG22913A1 (en)
CH585100A5 (en)
BG22245A1 (en)
BG22223A1 (en)
CH585634A5 (en)
CH586541A5 (en)
CH604382A5 (en)